Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | -0.28% | -0.83% | -17.81% |
May. 09 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 36.1M | Sales 2025 * | 47.4M | Capitalization | 92.74M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 2.57 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.96 x |
P/E ratio 2024 * |
-60.2
x | P/E ratio 2025 * |
13.4
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Eton Pharmaceuticals, Inc.
1 day | -0.82% | ||
1 week | +1.69% | ||
Current month | +1.69% | ||
1 month | +5.09% | ||
3 months | -19.78% | ||
6 months | +0.28% | ||
Current year | -17.58% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 17-05-31 |
James Gruber
DFI | Director of Finance/CFO | 52 | 22-04-10 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-05-31 | |
Paul Maier
BRD | Director/Board Member | 76 | 17-09-13 |
Norbert Riedel
CHM | Chairman | 66 | 17-09-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 3.6 | -0.28% | 6 818 |
24-06-07 | 3.61 | -0.82% | 37,691 |
24-06-06 | 3.64 | 0.00% | 13,842 |
24-06-05 | 3.64 | +1.11% | 8,520 |
24-06-04 | 3.6 | -0.83% | 14,874 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.58% | 92.74M | |
+18.84% | 80.5B | |
+15.08% | 9.15B | |
-14.14% | 4.9B | |
+43.39% | 4.49B | |
+18.90% | 4.44B | |
+9.11% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- ETON Stock